Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 3 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Clinical Experience with [225Ac]Ac-PSMA Treatment in Patients with [177Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med. 2023 Oct;64(10):1574-1580. doi: 10.2967/jnumed.123.265546. Epub 2023 Aug 24.
J Nucl Med. 2023.
PMID: 37620050
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance.
Akcay K, Kibar A, Sahin OE, Demirbilek M, Beydagi G, Asa S, Aghazada F, Toklu T, Selcuk NA, Onal B, Kabasakal L.
Akcay K, et al. Among authors: beydagi g.
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1467-1475. doi: 10.1007/s00259-023-06556-y. Epub 2023 Dec 19.
Eur J Nucl Med Mol Imaging. 2024.
PMID: 38112777
Item in Clipboard
Initial Findings on the Use of [225Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors.
Demirci E, Alan Selçuk N, Beydağı G, Ocak M, Toklu T, Akçay K, Kabasakal L.
Demirci E, et al. Among authors: beydagi g.
Mol Imaging Radionucl Ther. 2023 Oct 20;32(3):226-232. doi: 10.4274/mirt.galenos.2023.38258.
Mol Imaging Radionucl Ther. 2023.
PMID: 37870290
Free PMC article.
Item in Clipboard
Revision of the Histopathological Examination Following 68Ga-DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis.
Alan Selçuk N, Akçay K, Beydağı G, Sönmez Ö, Çelik S, Öven BB, Kabasakal L.
Alan Selçuk N, et al. Among authors: beydagi g.
Mol Imaging Radionucl Ther. 2024 Jun 28;33(2):134-137. doi: 10.4274/mirt.galenos.2024.89106.
Mol Imaging Radionucl Ther. 2024.
PMID: 38949561
Free article.
Item in Clipboard
Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer.
Kınıkoğlu O, Öven BB, Çelik S, Alan Selçuk N, Beydağı G, Akçay K, Kabasakal L.
Kınıkoğlu O, et al. Among authors: beydagi g.
J Clin Med. 2024 Aug 6;13(16):4585. doi: 10.3390/jcm13164585.
J Clin Med. 2024.
PMID: 39200727
Free PMC article.
Item in Clipboard
Cite
Cite